Our global, grassroots effort brings new hope to families affected by Aspartylglucosaminuria
We are thrilled to share that the U.S. Food and Drug Administration (FDA) has given approval to the start of a clinical trial for the treatment of the ultra-rare disease Aspartylglucosaminuria (AGU) 🧬✨
